Investing.com –Asian currencies declined on Friday, led by sharp losses in the South Korean won and Malaysian ringgit, as ...

DeepSeek R1 is available as an Nvidia Inference Microservice (NIM) preview on the company’s website, Nvidia said in a statement. NIM is a service that allows developers to deploy and use AI programs ...

Investing.com-- Asian stocks were a mixed bag on Friday as investors grappled with the prospect of trade tariffs under U.S. President Donald Trump, who threatened to impose steep tariffs on the BRICS ...

Australia's S&P/ASX 200 benchmark index rose 0.4% to 8,524.60 points as of 02:32 GMT, after reaching a record high of ...

Investing.com-- Oil prices rose in Asian trade on Friday, benefiting from some dip buying, and were headed for a second week of losses as traders fretted over the prospect of trade tariffs under U.S.

Investing.com-- Vertex Pharmaceuticals Inc (NASDAQ: VRTX) shares jumped in extended trading on Thursday, following the U.S. Food and Drug Administration's approval of JOURNAVX, the company's new ...

S&P 500 Futures inched 0.1% higher to 6,104.75 points, while Nasdaq 100 Futures rose 0.3% to 21,695.50 points by 18:40 ET (23:40 GMT). Dow Jones Futures ticked up 0.1% to 45,076.0 points.

DeepSeek- which is backed by Chinese hedge fund High-Flyer- had said in July 2022 that it owned and operated a cluster of ...

SK Hynix is the sole supplier of the advanced HBM chips to Nvidia, and had recently clocked a bumper fourth-quarter profit on ...

The December increase comes as several local exporters ramped up output and overseas shipments to front-load sales before the ...

Investing.com-- Consumer price index inflation in Tokyo grew as expected in January, hitting a near two-year high as strong private spending continued to underpin inflation, with a reading on ...

Today, the U.S. Food and Drug Administration (FDA) gave its approval to Vertex Pharmaceuticals' (NASDAQ: NASDAQ:VRTX) Journavx (suzetrigine) 50 milligram oral tablets. This new drug is a non-opioid ...